In summary, our study employed a range of machine learning algorithms to identify the PANoptosis biomarker SPP1 in RA patients, which was subsequently validated in an independent external dataset, demonstrating its elevated expression. The gene discussed is SPP1; the disease is rheumatoid arthritis.